The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The relationship of B7H3 expression to androgen and prostate cancer outcomes in a large natural history cohort of men undergoing prostatectomy.
 
Ashley Ross
No Relationships to Disclose
 
Benjamin Benzon
No Relationships to Disclose
 
Shuang Zhao
Employment - PFS Genomics (I)
Travel, Accommodations, Expenses - GenomeDx
 
Mandeep Takhar
Employment - GenomeDx
Stock and Other Ownership Interests - GenomeDx
 
Michael Haffner
No Relationships to Disclose
 
Nicholas Erho
Employment - GenomeDx
Stock and Other Ownership Interests - GenomeDx
 
Paula Hurley
Consulting or Advisory Role - Loxo (I); Novartis (I)
Other Relationship - Foundation Medicine (I); Genomic Health (I)
 
Jeffrey J. Tosoian
No Relationships to Disclose
 
Mohammed Alshalalfa
Employment - GenomeDx
Stock and Other Ownership Interests - GenomeDx
 
Stephanie Glavaris
No Relationships to Disclose
 
Brian Simons
No Relationships to Disclose
 
Phuoc T. Tran
Consulting or Advisory Role - Astellas Pharma; GenomeDx; Regeneron
Research Funding - Astellas Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
 
Elai Davicioni
Employment - GenomeDx
Leadership - GenomeDx
Stock and Other Ownership Interests - GenomeDx
 
Jeffrey Karnes
No Relationships to Disclose
 
Edward M. Schaeffer
Consulting or Advisory Role - GenomeDx
 
Charles G. Drake
No Relationships to Disclose
 
Felix Yi-Chung Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Consulting or Advisory Role - Celgene; GenomeDx; Medivation/Astellas
Research Funding - Celgene; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)